MAXIMA Study: A Study of Maintenance Therapy With MabThera (Rituximab) in Patients With Non-Hodgkin's Lymphoma.

NCT00430352 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

545

Enrollment

INDUSTRY

Sponsor class

Conditions

Non-Hodgkin's Lymphoma

Interventions

DRUG: rituximab [MabThera/Rituxan]

Sponsor

Hoffmann-La Roche